Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Microglia: Dynamic Mediators of Synapse Development and Plasticity.
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
Epidemiology and Current Treatment of Neuromyelitis Optica: A Systematic Review.
White matter integrity in polydrug users in relation to attachment and personality: a controlled diffusion tensor imaging study.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
IFN-β differentially regulates the function of T cell subsets in MS and EAE.
Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice.
Intracerebroventricular injection of lipopolysaccharide increases gene expression of connexin32 gap junction in rat hippocampus.
Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Behcet's disease.
A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
[Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice].
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Guwiyang Wurra-'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
Metabolite Changes in Normal Appearing Cervical Spinal Cord in Two Patients with Multiple Sclerosis. A Proton MR Spectroscopic Analysis.
Purinergic signalling in the urinary tract in health and disease.
Acute demyelinating events following vaccines - a case centered analysis.
[Disease-modifying drugs in pediatric patients with multiple sclerosis].
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
Pages
« first
‹ previous
…
703
704
705
706
707
708
709
710
711
…
next ›
last »